Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1350259 | 0.97 | — | — | |
| SCHEMBL232280 | 0.97 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL28714458 | 0.97 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL2685144 | 0.97 | ALDH1A1 (0.32) | ALDH1A1 | |
| Hydrochloric Acid SCHEMBL19100530 | 0.94 | — | — | |
| Hydrochloric Acid SCHEMBL23748065 | 0.93 | ALDH1A1 (0.31) | ALDH1A1 | |
| Hydrochloric Acid SCHEMBL17215574 | 0.93 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL8303206 | 0.93 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL15100 | 0.93 | ALDH1A1 (0.33) | ALDH1A1 | |
| Hydrochloric Acid SCHEMBL21586132 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109232385-B | Preparation method of magnesium dichloride (2,2,6, 6-tetramethylpiperidine) lithium salt | 阜新孚隆宝医药科技有限公司 | 2022-02-08 | — | — | CN | claimed |
| CN-109232385-A | A kind of preparation method of magnesium dichloride (2,2,6,6- tetramethyl piperidine) lithium salts | 阜新孚隆宝医药科技有限公司 | 2019-01-18 | — | — | CN | claimed |
| CN-109232385-B | Preparation method of magnesium dichloride (2,2,6, 6-tetramethylpiperidine) lithium salt | 阜新孚隆宝医药科技有限公司 | 2022-02-08 | — | — | CN | disclosed |
| CN-109232385-B | Preparation method of magnesium dichloride (2,2,6, 6-tetramethylpiperidine) lithium salt | 阜新孚隆宝医药科技有限公司 | 2022-02-08 | — | — | CN | disclosed |
| CN-113508118-A | Fused tricyclic compounds useful as anticancer agents | 阿斯利康(瑞典)有限公司 | 2021-10-15 | — | — | CN | disclosed |
| CN-109232385-A | A kind of preparation method of magnesium dichloride (2,2,6,6- tetramethyl piperidine) lithium salts | 阜新孚隆宝医药科技有限公司 | 2019-01-18 | — | — | CN | disclosed |
| CN-109232385-A | A kind of preparation method of magnesium dichloride (2,2,6,6- tetramethyl piperidine) lithium salts | 阜新孚隆宝医药科技有限公司 | 2019-01-18 | — | — | CN | disclosed |
| CN-107635992-A | Tricyclic heterocyclic compounds useful as TNF inhibitors | 百时美施贵宝公司 | 2018-01-26 | — | — | CN | disclosed |
| EP-3271361-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS USEFUL AS INHIBITORS OF TNF | Bristol-Myers Squibb Company (US) | 2018-01-24 | — | — | EP | disclosed |
| WO-2016149437-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS USEFUL AS INHIBITORS OF TNF | BRISTOL-MYERS SQUIBB COMPANY (US) | 2016-09-22 | — | — | WO | disclosed |